- Drugs
- Wednesday, 14 Feb 2024
Non-Gelatin Empty Capsules Market is expected to reach US$ 4.64 billion by 2030
Vitamins and Dietary Supplements Segment to Lead Non-Gelatin Empty Capsules Market During 2022–2030
According to our new research study on “Non-Gelatin empty capsules Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Application, and End User,” the market size is expected to grow from US$ 2.33 billion in 2022 to US$ 4.64 billion by 2030; it is estimated to register a CAGR of 9.0% during 2022–2030. The non-gelatin empty capsules market growth is attributed to the growing use of HPMC non-gelatin empty capsules in the pharmaceuticals industry and the ongoing proliferation of the nutraceuticals industry. A rising focus on sustainable packaging is likely to provide growth opportunities for the market. However, the lack of awareness and high costs of non-gelatin empty capsules hinder the market growth.
Non-gelatin empty capsules are widely used in the pharmaceutical and nutraceutical industries as an alternative to gelatin capsules. These capsules are made from plant cellulose or starch derivatives, making them suitable for people with dietary restrictions or religious beliefs that prohibit the consumption of gelatin.
Non-Gelatin Empty Capsules Market, by Region, 2022 (%)
To get sample Copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00038989
Source: The Insight Partners Analysis
The non-gelatin empty capsules market is expected to grow significantly during the forecast period owing to the rising demand for vegetarian and vegan products, coupled with increasing awareness about the benefits and drawbacks of gelatin-based capsules. Furthermore, the surging preference for natural and organic products, and the increasing involvement of regulatory bodies in promoting non-animal products are likely to favor the non-gelatin empty capsules market in the future.
The non-gelatin empty capsules market report emphasizes on the key factors impacting the market and showcases the developments of prominent players. The rising acceptance of non-gelatin capsules, strategic collaborations between suppliers and gelatin manufacturers, and an increase in R&D activities and clinical trials are a few of the major factors that are expected to boost the market in the coming years.
Based on type, the non-gelatin empty capsules market is bifurcated into HPMC capsules and pullulan capsules. The HPMC capsules segment held a larger non-gelatin empty capsules market share in 2022. The pullulan capsules segment is expected to register a higher CAGR of 9.9% during 2022–2030. Based on end user, the market is segmented into pharmaceutical industry, nutraceutical industry, cosmetics industry, and research laboratories. The pharmaceutical industry segment accounted for the largest non-gelatin empty capsules market share in 2022. The same segment is anticipated to register the highest CAGR of 9.4% during 2022–2030. Due to various motives such as improved palatability and faster absorption, capsules are the most common solid dosage forms. HPMC capsules have received approval from the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA), among other regulatory authorities, for use in pharmaceutical purposes. Regulatory compliance is a top priority for pharmaceutical companies to ensure the safety and effectiveness of their products. The acceptance of HPMC capsules by these organizations simplifies the approval process for new drug formulations and provides some guarantee of the safety of the final product. Thus, the expansion of the pharmaceutical industry with the burgeoning demand for vegan and vegetarian medication among people contributes to the growth of the non-gelatin empty capsules market.
Growing Penetration of Veganism to Bring New Trends in Market in Coming Years
In recent years, the trend toward veganism or a vegan diet has increased among consumers worldwide due to nutritional, environmental, and ethical factors. According to the Vegetarianism in America study published by Vegetarian Times Magazine in 2021, the vegan population in the US is increasing rapidly. Nearly 9.7 million people in the country follow a vegetarian diet. Additionally, veganism is highly prevalent among health-conscious consumers as awareness of consuming plant-based products has increased. According to the American Dietetic Association's 2021 study, consumers prefer a vegan diet because it lowers the risk of type 2 diabetes, heart disease, and obesity. Although veganism is one of the healthiest diets, a portion of the population lacks some essential nutrients for healthy growth. Vegan dietary supplements with optimized ingredient profiles for specific nutritional needs such as vegan protein supplements, vegan iron supplements, vegan B12 supplements, and vegan vitamin D supplements are becoming increasingly popular among vegans and flexitarians. The increasing popularity of veganism among health-conscious populations further boosts the sales of non-gelatin empty capsules. Thus, the growing vegan population is expected to lead to notable non-gelatin empty capsules market trends in the coming years.
Lack of Awareness and High Costs of Non-Gelatin Empty Capsules Hinder Market Growth
As consumers and manufacturers are unaware of the existence and benefits of gelatin-free empty capsules, they often opt for the well-known traditional gelatin capsules. This lack of awareness limits the demand for empty gelatin-free capsules and creates a mismatch between consumer demand and available products. Further, the limited availability of these capsules in certain regions or markets exacerbates the problem and makes it difficult for the companies in the non-gelatin empty capsules market to gain a foothold or expand. Further, the high manufacturing cost of gelatin-free empty capsules due to special raw material requirements and production processes is another factor hampering the non-gelatin empty capsules market growth.
Key players identified and evaluated for non-gelatin empty capsules market analysis include LonzaGroup (Capsugel), Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.), Erawat Pharma Limited, ACG Worldwide, Suheung Capsule, Sunil Healthcare, CapsCanada Corporation, BrightCaps GmbH, Natural Capsules Limited, and Healthcaps India Limited.
The market, by type, is bifurcated into HPMC capsules and pullulan capsules. The market, based on application, is divided into antibiotics and antibacterial drugs, vitamins and dietary supplements, antacids and antiflatulent preparations, and others. In terms of end user, the market is categorized into pharmaceutical industry, nutraceutical industry, cosmetics industry, and research laboratories.
The scope of the non-gelatin empty capsules market report encompasses North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
North America holds the second-largest share of the market. The non-gelatin empty capsules market size in North America was valued at US$ 0.63 billion in 2022 and is projected to reach US$ 1.28 billion by 2030; it is expected to register a CAGR of 9.2% during 2022–2030. However, Asia Pacific is expected to record the highest CAGR in the market during the forecast period. The projected market growth in this region is attributed to the availability of highly functional manufacturing units and contract manufacturing facilities in the region. In addition, the introduction of strategies by the healthcare systems to implement preventive measures for positive treatment outcomes prompts the growth of the non-gelatin empty capsules market in China.
Contact Us
Contact Person: Content Team
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com
Related Industry Updates
Glioma Treatment Market is expected to reach US$ 8,291.3 million by 2030
Sep 18, 2023
ADHD Therapeutics Market is expected to reach US$ 64,742.37 million by 2030
Jan 29, 2024
Christopher Hite Joins Royalty Pharma
Feb 28, 2020
Synthetic Menthol Market Overview | COVID-19 Pandemic Impact, Competitive Landscape, Size, Value Demand, Regional Analysis and Forecast to 2027
May 06, 2021
Asia Pacific Starch Softgel Capsules Market Size, Share, Demand, Analysis and Forecast To 2027 | Hunan Er-Kang Pharmaceutical Co. Ltd,Softcaps,Fuji Capsule Co. Ltd.,Aenova Holding GmbH,Sirio Pharma Co. Ltd.
Oct 15, 2020
Microbiome Therapeutics Market is expected to reach US$ 813.38 million by 2030
Nov 08, 2023
Radioactive Tracer Market is expected to reach US$ 54,296.57 million by 2030
Aug 11, 2023